Biogen (BIIB) Financials: Revenue & Earnings
BIIB$249.59-3.14 -1.24%
$36.88B
Market Cap
44.41
P/E
20.22
Forward P/E
37
Score
Biogen (BIIB) Financials: Revenue & Earnings
BIIB price $249.59 -3.14 -1.24%
- Ticker
- BIIB
- Price
- $249.59
- Change
- -3.14 -1.24%
- Market cap ?
- $36.88B
- P/E ?
- 44.41
- Forward P/E ?
- 20.22
- Dividend yield ?
- 0.00%
- Beta ?
- 0.17
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stocklytics score
- 37
- Value
- 46
- Quality
- 47
- Growth
- 19
Stocklytics score rationale: value 46, quality 47, growth 19.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 11448800000 | 12273900000 | 13452900000 | 14377900000 | 13444600000 | 10981700000 | 10173400000 | 9835600000 | 9675900000 | 9810600000 |
Biogen Inc. is a leading biotechnology firm dedicated to the discovery, development, production, and distribution of treatments for complex neurological and neurodegenerative conditions. Its established portfolio includes a range of medications addressing multiple sclerosis (MS), such as TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy (SMA), Biogen provides SPINRAZA, while…
Fair value
BIIB fair value $342.43. Price $249.59. Price is 27% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 98% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.42B. Growth 13.54%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 147.75M. Net debt 3.94B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-05 | — | 3.14 | — | 2.61B |
| 2026-10-28 | 2.62 | 1.99 | 2.80B | 2.63B |
| 2026-07-29 | 3.60 | 2.94 | 2.74B | 2.46B |
| 2026-04-29 | 3.57 | 3.05 | 2.48B | 2.29B |
| 2026-02-06 | 1.99 | 1.63 | 2.28B | 2.20B |
| 2025-10-30 | 4.81 | 3.88 | 2.45B | 2.34B |
| 2025-07-31 | 5.47 | 3.90 | 2.65B | 2.33B |
| 2025-05-01 | 3.02 | 2.90 | 2.43B | 2.23B |
| 2025-02-12 | 3.44 | 3.43 | 2.45B | 2.41B |
| 2024-10-30 | 4.08 | 3.77 | 2.47B | 2.43B |
| 2024-08-01 | 5.28 | 4.07 | 2.35B | 2.39B |
| 2024-04-24 | 3.67 | 3.47 | 2.29B | 2.31B |
| 2024-02-13 | 2.95 | 3.16 | 2.39B | 2.47B |
| 2023-11-08 | 4.36 | 3.99 | 2.53B | 2.39B |
| 2023-07-25 | 4.02 | 3.77 | 2.46B | 2.37B |
| 2023-04-25 | 3.40 | 3.28 | 2.46B | 2.34B |
| 2023-02-15 | 4.05 | 3.48 | 2.54B | 2.45B |
| 2022-10-25 | 4.77 | 4.13 | 2.51B | 2.47B |
| 2022-07-20 | 5.25 | 4.06 | 2.59B | 2.47B |
| 2022-05-03 | 3.62 | 4.41 | 2.53B | 2.50B |
| 2022-02-03 | 3.39 | 3.32 | 2.73B | 2.62B |
| 2021-10-20 | 4.77 | 4.15 | 2.78B | 2.67B |
| 2021-07-22 | 5.68 | 4.57 | 2.77B | 2.68B |
| 2021-04-22 | 5.34 | 5.06 | 2.69B | 2.67B |
| 2021-02-03 | 4.58 | 4.93 | 2.85B | 3.02B |
| 2020-10-21 | 8.84 | 8.06 | 3.38B | 1.07B |
| 2020-07-22 | 10.26 | 8.03 | 3.68B | 2.88B |
| 2020-04-22 | 9.14 | 7.73 | 3.53B | 2.99B |
| 2020-01-30 | 8.34 | 8.02 | 3.67B | 3.53B |
| 2019-10-22 | 9.17 | 8.27 | 3.60B | 3.25B |
| 2019-07-23 | 9.15 | 7.53 | 3.62B | 2.98B |
| 2019-04-24 | 6.98 | 6.87 | 3.49B | 3.43B |
| 2019-01-29 | 6.99 | 6.72 | 3.53B | 3.40B |
| 2018-10-23 | 7.40 | 6.78 | 3.44B | 3.15B |
| 2018-07-24 | 5.80 | 5.22 | 3.36B | 3.02B |
| 2018-04-24 | 6.05 | 5.94 | 3.13B | 3.07B |
| 2018-01-25 | 5.26 | 5.44 | 3.31B | 3.43B |
| 2017-10-24 | 6.31 | 5.73 | 3.08B | 2.79B |
| 2017-07-25 | 5.04 | 4.41 | 3.08B | 2.69B |
| 2017-04-25 | 5.20 | 4.97 | 2.81B | 2.69B |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-02 | Godbout Sean | Buy | 27 | — | — |
| 2026-10-02 | Godbout Sean | Sell | 8 | $219.88 | 1.76K |
| 2026-10-02 | Godbout Sean | Sell | 27 | — | — |
| 2026-10-01 | Godbout Sean | Buy | 985 | — | — |
| 2026-09-01 | Parini Michael | Buy | 7.41K | — | — |
| 2026-08-04 | Minor Lloyd | Sell | 593 | $200.96 | 119.17K |
| 2026-08-03 | Parini Michael | Other | 0 | — | — |
| 2026-08-03 | Minor Lloyd | Sell | 593 | $203.34 | 120.58K |
| 2026-06-09 | HAWKINS WILLIAM A | Buy | 1.50K | — | — |
| 2026-06-09 | SHERWIN STEPHEN A | Buy | 1.50K | — | — |
| 2026-06-09 | Rowinsky Eric K | Buy | 1.50K | — | — |
| 2026-06-09 | Mantas Jesus B | Buy | 1.50K | — | — |
| 2026-06-09 | LANGER SUSAN | Buy | 1.50K | — | — |
| 2026-06-09 | Patolawala Monish D | Buy | 1.50K | — | — |
| 2026-06-09 | Pangalos Menelas N | Buy | 1.50K | — | — |
| 2026-06-09 | Pangalos Menelas N | Buy | 2.37K | — | — |
| 2026-06-09 | Pangalos Menelas N | Sell | 2.37K | — | — |
| 2026-06-09 | Minor Lloyd | Buy | 1.50K | — | — |
| 2026-06-09 | Freire Maria C | Buy | 2.00K | — | — |
| 2026-05-01 | Keeney Adam | Buy | 939 | — | — |
| 2026-05-01 | Keeney Adam | Sell | 455 | $187.06 | 85.11K |
| 2026-05-01 | Keeney Adam | Sell | 939 | — | — |
| 2026-04-01 | Godbout Sean | Buy | 181 | — | — |
| 2026-04-01 | Godbout Sean | Sell | 54 | $183.78 | 9.92K |
| 2026-04-01 | Godbout Sean | Sell | 181 | — | — |
| 2026-02-13 | Viehbacher Christopher | Buy | 38.02K | — | — |
| 2026-02-13 | Singhal Priya | Buy | 10.56K | — | — |
| 2026-02-13 | Murphy Nicole | Buy | 10.56K | — | — |
| 2026-02-13 | Kramer Robin | Buy | 8.45K | — | — |
| 2026-02-13 | Keeney Adam | Buy | 8.03K | — | — |
| 2026-02-13 | Izzar Rachid | Buy | 7.39K | — | — |
| 2026-02-13 | Grogan Jane | Buy | 8.45K | — | — |
| 2026-02-13 | Gregory Ginger | Buy | 8.03K | — | — |
| 2026-02-13 | Godbout Sean | Buy | 1.80K | — | — |
| 2026-02-13 | ALEXANDER SUSAN H | Buy | 8.45K | — | — |
| 2026-02-12 | Murphy Nicole | Buy | 3 | $195.03 | 585 |
| 2026-02-09 | Singhal Priya | Sell | 2.66K | $199.83 | 531.55K |
| 2026-02-06 | Viehbacher Christopher | Buy | 15.45K | — | — |
| 2026-02-06 | Viehbacher Christopher | Sell | 15.45K | — | — |
| 2026-02-06 | Viehbacher Christopher | Sell | 6.62K | $201.18 | 1.33M |
| 2026-02-06 | Viehbacher Christopher | Buy | 9.01K | — | — |
| 2026-02-06 | Viehbacher Christopher | Sell | 4.36K | $201.18 | 876.34K |
| 2026-02-06 | Viehbacher Christopher | Sell | 9.01K | — | — |
| 2026-02-06 | Singhal Priya | Buy | 4.68K | — | — |
| 2026-02-06 | Singhal Priya | Sell | 1.41K | $201.18 | 284.07K |
| 2026-02-06 | Singhal Priya | Sell | 4.68K | — | — |
| 2026-02-06 | Singhal Priya | Buy | 2.22K | — | — |
| 2026-02-06 | Singhal Priya | Sell | 1.06K | $201.18 | 212.45K |
| 2026-02-06 | Singhal Priya | Sell | 2.22K | — | — |
| 2026-02-06 | Murphy Nicole | Buy | 4.68K | — | — |
| 2026-02-06 | Murphy Nicole | Sell | 1.41K | $201.18 | 283.26K |
| 2026-02-06 | Murphy Nicole | Buy | 1.94K | — | — |
| 2026-02-06 | Murphy Nicole | Sell | 914 | $201.18 | 183.88K |
| 2026-02-06 | Murphy Nicole | Buy | 2.10K | — | — |
| 2026-02-06 | Murphy Nicole | Sell | 1.02K | $201.18 | 204.60K |
| 2026-02-06 | Murphy Nicole | Sell | 4.68K | — | — |
| 2026-02-06 | Murphy Nicole | Sell | 1.94K | — | — |
| 2026-02-06 | Murphy Nicole | Sell | 2.10K | — | — |
| 2026-02-06 | Kramer Robin | Buy | 3.51K | — | — |
| 2026-02-06 | Kramer Robin | Sell | 1.06K | $201.18 | 213.85K |
| 2026-02-06 | Kramer Robin | Buy | 703 | — | — |
| 2026-02-06 | Kramer Robin | Sell | 207 | $201.18 | 41.64K |
| 2026-02-06 | Kramer Robin | Buy | 789 | — | — |
| 2026-02-06 | Kramer Robin | Sell | 273 | $201.18 | 54.92K |
| 2026-02-06 | Kramer Robin | Sell | 3.51K | — | — |
| 2026-02-06 | Kramer Robin | Sell | 703 | — | — |
| 2026-02-06 | Kramer Robin | Sell | 789 | — | — |
| 2026-02-06 | Keeney Adam | Buy | 3.28K | — | — |
| 2026-02-06 | Keeney Adam | Sell | 3.28K | — | — |
| 2026-02-06 | Keeney Adam | Sell | 994 | $201.18 | 199.97K |
| 2026-02-06 | Keeney Adam | Buy | 1.80K | — | — |
| 2026-02-06 | Keeney Adam | Sell | 589 | $201.18 | 118.50K |
| 2026-02-06 | Keeney Adam | Sell | 1.80K | — | — |
| 2026-02-06 | Izzar Rachid | Buy | 3.04K | — | — |
| 2026-02-06 | Izzar Rachid | Sell | 775 | $201.18 | 155.91K |
| 2026-02-06 | Izzar Rachid | Buy | 1.80K | — | — |
| 2026-02-06 | Izzar Rachid | Sell | 458 | $201.18 | 92.14K |
| 2026-02-06 | Izzar Rachid | Buy | 2.04K | — | — |
| 2026-02-06 | Izzar Rachid | Sell | 805 | $201.18 | 161.95K |
| 2026-02-06 | Izzar Rachid | Sell | 3.04K | — | — |
| 2026-02-06 | Izzar Rachid | Sell | 1.80K | — | — |
| 2026-02-06 | Izzar Rachid | Sell | 2.04K | — | — |
| 2026-02-06 | Grogan Jane | Buy | 1.87K | — | — |
| 2026-02-06 | Grogan Jane | Sell | 584 | $201.18 | 117.49K |
| 2026-02-06 | Grogan Jane | Sell | 1.87K | — | — |
| 2026-02-06 | Grogan Jane | Buy | 1.39K | — | — |
| 2026-02-06 | Grogan Jane | Sell | 407 | $201.18 | 81.88K |
| 2026-02-06 | Grogan Jane | Sell | 1.39K | — | — |
| 2026-02-06 | Gregory Ginger | Buy | 3.75K | — | — |
| 2026-02-06 | Gregory Ginger | Sell | 1.13K | $201.18 | 227.74K |
| 2026-02-06 | Gregory Ginger | Buy | 1.80K | — | — |
| 2026-02-06 | Gregory Ginger | Sell | 666 | $201.18 | 133.99K |
| 2026-02-06 | Gregory Ginger | Buy | 1.64K | — | — |
| 2026-02-06 | Gregory Ginger | Sell | 791 | $201.18 | 159.13K |
| 2026-02-06 | Gregory Ginger | Sell | 3.75K | — | — |
| 2026-02-06 | Gregory Ginger | Sell | 1.80K | — | — |
| 2026-02-06 | Gregory Ginger | Sell | 1.64K | — | — |
| 2026-02-06 | Godbout Sean | Buy | 517 | — | — |
| 2026-02-06 | Godbout Sean | Sell | 180 | $201.18 | 36.21K |
| 2026-02-06 | Godbout Sean | Sell | 517 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 1.10K, holders +40 vs prior quarter. Ownership 97.18%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FMR LLC | 18.22M | 5.41M | +42.24% | 3.94B |
| BLACKROCK, INC. | 15.99M | 11.13K | +0.07% | 3.45B |
| PRIMECAP MANAGEMENT CO/CA/ | 15.15M | 397.00K | +2.69% | 3.27B |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.65M | 113.70K | +1.19% | 2.09B |
| STATE STREET CORP | 7.34M | 176.41K | +2.46% | 1.59B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.60M | 73.21K | +1.12% | 1.43B |
| GEODE CAPITAL MANAGEMENT, LLC | 4.45M | 106.69K | +2.46% | 957.94M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.12M | 155.83K | +5.26% | 673.56M |
| NORGES BANK | 2.58M | 2.58M | New | 557.44M |
| MORGAN STANLEY | 2.41M | 240.33K | +11.07% | 520.98M |
| AQR CAPITAL MANAGEMENT LLC | 1.94M | 13.30K | +0.69% | 416.93M |
| JPMORGAN CHASE & CO | 1.82M | -192.87K | -9.57% | 394.95M |
| INVESCO LTD. | 1.80M | 58.69K | +3.36% | 389.76M |
| AMUNDI | 1.52M | 726.00K | +91.80% | 327.73M |
| LEGAL & GENERAL GROUP PLC | 1.49M | 143.46K | +10.63% | 322.64M |
| NORTHERN TRUST CORP | 1.43M | -17.09K | -1.18% | 308.86M |
| BOSTON PARTNERS | 1.26M | -436.65K | -25.68% | 272.85M |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 1.26M | -122.40K | -8.89% | 271.19M |
| GOLDMAN SACHS GROUP INC | 1.23M | 179.30K | +17.06% | 265.84M |
| DIMENSIONAL FUND ADVISORS LP | 1.15M | 69.45K | +6.44% | 248.17M |
| PACER ADVISORS, INC. | 1.12M | 462.57K | +70.04% | 242.63M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.12M | -31.73K | -2.76% | 241.48M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 1.12M | 1.12M | New | 241.48M |
| BANK OF AMERICA CORP /DE/ | 1.12M | -40.14K | -3.47% | 241.17M |
| UBS GROUP AG | 1.03M | 506.70K | +96.80% | 222.57M |
Earnings and financials
Biogen Inc. (BIIB) trades at $249.59, with a market cap of $36.88B and a trailing P/E of 44.41. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 11448800000 | 12273900000 | 13452900000 | 14377900000 | 13444600000 | 10981700000 | 10173400000 | 9835600000 | 9675900000 | 9810600000 |
Insights · Dividends · Forecast · Financials · Learn